Patient Square Capital has completed its acquisition of Premier, Inc., finalizing a transaction that values the healthcare improvement company at $2.6 billion. As a result of the closing, Premier’s common stock has stopped trading and will be delisted from Nasdaq effective November 25, 2025. Under the agreement’s terms, Premier stockholders will receive $28.25 in cash per share.
Premier is known for providing technology-driven healthcare improvement services, including data and analytics, supply chain solutions, and consulting offerings that support hospitals, health systems, and other stakeholders across the healthcare ecosystem. The company is headquartered in Charlotte, North Carolina, and serves providers, suppliers, payers, and policymakers through integrated intelligence and large-scale industry collaborations.
Patient Square Capital, a healthcare-focused investment firm with more than $15 billion in assets under management, emphasized its strategy of partnering with growth-oriented companies and management teams committed to improving health outcomes through innovation. The firm invests in businesses that advance patient care, strengthen communities, and expand opportunities for health-focused technologies and services.
Support: Advisors on the transaction included Goldman Sachs and BofA Securities as financial advisors to Premier, along with Wachtell, Lipton, Rosen & Katz as legal counsel, and Joele Frank handling strategic communications. Cravath, Swaine & Moore acted as legal advisor to the Transaction Committee of Premier’s Board of Directors. For Patient Square, Kirkland & Ellis served as legal counsel, Ropes & Gray provided healthcare legal counsel, Jefferies LLC and Santander acted as financial advisors, and Perella Weinberg Partners LP advised on debt capital markets.
